PROSIDION LIMITED SCIENTIFIC ADVISORY BOARD AND CONSULTING AGREEMENTScientific Advisory Board and Consulting Agreement • February 27th, 2009 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • England and Wales
Contract Type FiledFebruary 27th, 2009 Company Industry JurisdictionThis Scientific Advisory Board and Consulting Agreement (this “Agreement”) is made and entered into as of December 16, 2008, and effective as of January 1, 2009 (the “Effective Date”), by and between Prosidion Limited, a company registered in England and Wales under registered number 4600121 with its registered office at Watlington Road, Oxford, UK OX4 6LT (the “Company”) and Dr. Daryl Granner, Professor, an individual with an address of 707 Light Hall, Vanderbilt University Medical Centre, Nashville, Tennessee 37232, USA (“Consultant ”).
PROSIDION LIMITED SCIENTIFIC ADVISORY BOARD AND CONSULTING AGREEMENTScientific Advisory Board and Consulting Agreement • February 13th, 2006 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • England and Wales
Contract Type FiledFebruary 13th, 2006 Company Industry JurisdictionThis Scientific Advisory Board and Consulting Agreement (this “Agreement”) is made and entered into as of February 10, 2006 (“the “Effective Date”) by and between Prosidion Limited, a company registered in England and Wales under registered number 4600121 with its registered office at Watlington Road, Oxford, UK OX4 6LT (the “Company”) and Dr Daryl Granner, Professor, an individual with an address of 707 Light Hall, Vanderbilt University Medical Centre, Nashville, Tennessee 37232, USA (“Consultant”).